JW Pharmaceutical Corporation – Product Pipeline Review

Global Markets Direct’s, ‘JW Pharmaceutical Corporation – Product Pipeline Review – 2016’, provides an overview of the JW Pharmaceutical Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by JW Pharmaceutical Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of JW Pharmaceutical Corporation

The report provides overview of JW Pharmaceutical Corporation including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses JW Pharmaceutical Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features JW Pharmaceutical Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate JW Pharmaceutical Corporation’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for JW Pharmaceutical Corporation

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding JW Pharmaceutical Corporation’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

JW Pharmaceutical Corporation Snapshot 5

JW Pharmaceutical Corporation Overview 5

Key Facts 5

JW Pharmaceutical Corporation - Research and Development Overview 6

Key Therapeutic Areas 6

JW Pharmaceutical Corporation - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Combination Treatment Modalities 11

Pipeline Products - Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

JW Pharmaceutical Corporation - Pipeline Products Glance 14

JW Pharmaceutical Corporation - Late Stage Pipeline Products 14

Phase III Products/Combination Treatment Modalities 14

JW Pharmaceutical Corporation - Clinical Stage Pipeline Products 15

Phase I Products/Combination Treatment Modalities 15

JW Pharmaceutical Corporation - Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

JW Pharmaceutical Corporation - Drug Profiles 18

(pitavastatin + valsartan) - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

CW-108F - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

CWF-0701 - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

CWF-0771 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

CWF-07pre03 - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

CWF-0808 - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

CWF-09pre02 - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

CWP-232228 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

CWP-291 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

docetaxel - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

JWF-1103 - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

JWF-1201 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

JW Pharmaceutical Corporation - Pipeline Analysis 30

JW Pharmaceutical Corporation - Pipeline Products by Target 30

JW Pharmaceutical Corporation - Pipeline Products by Route of Administration 32

JW Pharmaceutical Corporation - Pipeline Products by Molecule Type 33

JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action 34

JW Pharmaceutical Corporation - Dormant Projects 36

JW Pharmaceutical Corporation - Locations And Subsidiaries 37

Head Office 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 3

List of Tables

List of Tables

JW Pharmaceutical Corporation, Key Facts 5

JW Pharmaceutical Corporation – Pipeline by Indication, 2016 8

JW Pharmaceutical Corporation – Pipeline by Stage of Development, 2016 9

JW Pharmaceutical Corporation – Monotherapy Products in Pipeline, 2016 10

JW Pharmaceutical Corporation – Combination Treatment Modalities in Pipeline, 2016 11

JW Pharmaceutical Corporation – Partnered Products in Pipeline, 2016 12

JW Pharmaceutical Corporation – Partnered Products/ Combination Treatment Modalities, 2016 13

JW Pharmaceutical Corporation – Phase III, 2016 14

JW Pharmaceutical Corporation – Phase I, 2016 15

JW Pharmaceutical Corporation – Preclinical, 2016 16

JW Pharmaceutical Corporation – Discovery, 2016 17

JW Pharmaceutical Corporation – Pipeline by Target, 2016 31

JW Pharmaceutical Corporation – Pipeline by Route of Administration, 2016 32

JW Pharmaceutical Corporation – Pipeline by Molecule Type, 2016 33

JW Pharmaceutical Corporation – Pipeline Products by Mechanism of Action, 2016 35

JW Pharmaceutical Corporation – Dormant Developmental Projects,2016 36

List of Figures

List of Figures

JW Pharmaceutical Corporation – Pipeline by Top 10 Indication, 2016 7

JW Pharmaceutical Corporation – Pipeline by Stage of Development, 2016 9

JW Pharmaceutical Corporation – Monotherapy Products in Pipeline, 2016 10

JW Pharmaceutical Corporation – Partnered Products in Pipeline, 2016 12

JW Pharmaceutical Corporation – Pipeline by Top 10 Target, 2016 30

JW Pharmaceutical Corporation – Pipeline by Route of Administration, 2016 32

JW Pharmaceutical Corporation – Pipeline by Molecule Type, 2016 33

JW Pharmaceutical Corporation – Pipeline Products by Top 10 Mechanism of Action, 2016 34

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports